Covid-19 vaccines

As of May 2021, four vaccines have been granted temporary authorization in the UK to prevent Covid-19 disease caused by the SARS-CoV-2 virus. These vaccines are manufactured by AstraZeneca, Pfizer-BioNTech, Moderna Biotech and Janssen Biotech Inc, respectively. In the USA, the FDA has granted Emergency Use Authorization (EUA) to the Pfizer-BioNTech, Moderna Biotech and Janssen vaccines. FDA Fact Sheets for the Pfizer-BioNTech, Moderna Biotech and Janssen Covid-19 vaccines are appended plus information on the AstraZeneca Covid-19 vaccine provided by the European Medicines Agency and the UK Medicines & Healthcare Products Regulatory Agency, respectively. Janssen Biotech Inc. is a Janssen Pharmaceutical Company of Johnson & Johnson.

In August 2021, the Pfizer-BioNTech Covid-19 Vaccine was granted FDA approval for the prevention of Covid-19 disease in individuals 16 years of age and older, and by November 2021 this recommendation had been extended to everyone age 5 years and older. The vaccine will continue to be available under emergency use authorization.

For a selection of reviews of the safety of approved Covid-19 vaccines in the general population and some emerging safety signals associated with these vaccines, please use this link: Covid-19 Vaccine

Investigational drugs for the treatment of Covid-19

Adverse reactions of drugs and classes of drugs which have been investigated for the treatment of Covid-19 since the emergence of the SARS-CoV-2 virus in January 2020 are searchable in Litt’s Drug Eruption & Reaction Database.